US Stock MarketDetailed Quotes

COLL Collegium Pharmaceutical

Watchlist
  • 30.020
  • -0.880-2.85%
Close Dec 18 16:00 ET
  • 29.110
  • -0.910-3.03%
Pre 04:09 ET
968.15MMarket Cap12.83P/E (TTM)

Collegium Pharmaceutical Key Stats

Collegium Pharmaceutical Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
155.57M
159.30M
+3.73M
Beat Est.
+13.80%
+16.53%
+2.40%
EPS
0.41
0.27
-0.14
Miss Est.
-32.25%
-49.06%
-34.67%
Buy

Nov 30, 2024

Collegium Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 181.592M--
--2024/Q4-- / 179.485M--
Nov 7, 20242024/Q3159.301M / 155.573M--
Aug 8, 20242024/Q2145.276M / 144.562M--
May 9, 20242024/Q1144.923M / 146.937M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 181.592M--
--2024/Q4-- / 179.485M--
Nov 7, 20242024/Q3159.301M / 155.573M--
Aug 8, 20242024/Q2145.276M / 144.562M--
May 9, 20242024/Q1144.923M / 146.937M--

Unlock Free Earnings Estimates

Collegium Pharmaceutical Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Buy

  • Buy

    60.00%
  • Hold

    40.00%
  • Sell

    0.00%

Price Target

No Data